Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 162 entries
Sorted by: Best Match Show Resources per page
Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario.

Hepatobiliary surgery and nutrition

Ierardi E, Sorrentino C, Principi M, Giorgio F, Losurdo G, Di Leo A.
PMID: 26312245
Hepatobiliary Surg Nutr. 2015 Aug;4(4):289-92. doi: 10.3978/j.issn.2304-3881.2015.02.01.

Intestinal microbiota is a "dynamic organ" influencing host metabolism, nutrition, physiology and immune system. Among its several interactions, the role of a phosphatidylcholine metabolite derived by gut flora activity, i.e., trimethylamine-N-oxide (TMAO), allows perceiving a novel insight in the...

Cite
Ierardi E, Sorrentino C, Principi M, et al. Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary Surg Nutr. 2015;4(4):289-92doi: 10.3978/j.issn.2304-3881.2015.02.01.
Ierardi, E., Sorrentino, C., Principi, M., Giorgio, F., Losurdo, G., & Di Leo, A. (2015). Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary surgery and nutrition, 4(4), 289-92. https://doi.org/10.3978/j.issn.2304-3881.2015.02.01
Ierardi, Enzo, et al. "Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario." Hepatobiliary surgery and nutrition vol. 4,4 (2015): 289-92. doi: https://doi.org/10.3978/j.issn.2304-3881.2015.02.01
Ierardi E, Sorrentino C, Principi M, Giorgio F, Losurdo G, Di Leo A. Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary Surg Nutr. 2015 Aug;4(4):289-92. doi: 10.3978/j.issn.2304-3881.2015.02.01. PMID: 26312245; PMCID: PMC4526767.
Copy Download .nbib Format: NLM
Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score.

Gastroenterology research and practice

Scardapane A, Ambrosi A, Salinaro E, Mancini ME, Principi M, Di Leo A, Lorusso F, Stabile Ianora AA, Angelelli G.
PMID: 26759554
Gastroenterol Res Pract. 2015;2015:159641. doi: 10.1155/2015/159641. Epub 2015 Nov 22.

Objectives. To retrospectively compare the results of the MRIA (magnetic resonance index of activity) with a modified MRIA (mMRIA), which was calculated excluding from MRIA formula the data of relative contrast enhancement (RCE). Materials and Methods. MR-E and corresponding...

Cite
Scardapane A, Ambrosi A, Salinaro E, et al. Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score. Gastroenterol Res Pract. 2015;2015:159641doi: 10.1155/2015/159641.
Scardapane, A., Ambrosi, A., Salinaro, E., Mancini, M. E., Principi, M., Di Leo, A., Lorusso, F., Stabile Ianora, A. A., & Angelelli, G. (2015). Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score. Gastroenterology research and practice, 2015159641. https://doi.org/10.1155/2015/159641
Scardapane, Arnaldo, et al. "Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score." Gastroenterology research and practice vol. 2015 (2015): 159641. doi: https://doi.org/10.1155/2015/159641
Scardapane A, Ambrosi A, Salinaro E, Mancini ME, Principi M, Di Leo A, Lorusso F, Stabile Ianora AA, Angelelli G. Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score. Gastroenterol Res Pract. 2015;2015:159641. doi: 10.1155/2015/159641. Epub 2015 Nov 22. PMID: 26759554; PMCID: PMC4670649.
Copy Download .nbib Format: NLM
Periprostatic Perineurioma, Description of a Case With Unusual Localization.

Urology case reports

Guerriero M, Pollio AM, Cuscunà D, Santoro P, Di Lallo A, Francario G, Torricelli P.
PMID: 27335795
Urol Case Rep. 2016 May 20;7:55-7. doi: 10.1016/j.eucr.2016.04.011. eCollection 2016 Jul.

Perineurioma is a rare entity, it is a benign peripheral nerve sheath tumor entirely composed of perineurial cells. A 62-year-old male patient was admitted to our hospital, suffering from scrotal and pelvic pain combined with a severe and continuous...

Cite
Guerriero M, Pollio AM, Cuscunà D, et al. Periprostatic Perineurioma, Description of a Case With Unusual Localization. Urol Case Rep. 2016;7:55-7doi: 10.1016/j.eucr.2016.04.011.
Guerriero, M., Pollio, A. M., Cuscunà, D., Santoro, P., Di Lallo, A., Francario, G., & Torricelli, P. (2016). Periprostatic Perineurioma, Description of a Case With Unusual Localization. Urology case reports, 755-7. https://doi.org/10.1016/j.eucr.2016.04.011
Guerriero, Massimiliano, et al. "Periprostatic Perineurioma, Description of a Case With Unusual Localization." Urology case reports vol. 7 (2016): 55-7. doi: https://doi.org/10.1016/j.eucr.2016.04.011
Guerriero M, Pollio AM, Cuscunà D, Santoro P, Di Lallo A, Francario G, Torricelli P. Periprostatic Perineurioma, Description of a Case With Unusual Localization. Urol Case Rep. 2016 May 20;7:55-7. doi: 10.1016/j.eucr.2016.04.011. eCollection 2016 Jul. PMID: 27335795; PMCID: PMC4909516.
Copy Download .nbib Format: NLM
Inguinal Hernia: Lap vs Open.

Hernia : the journal of hernias and abdominal wall surgery

Vassiliadis A, Zanoni A, Di Leo A, Zanella S, Lauro E, Moscatelli P, Ricci F, Huang H, Wada N, Furukawa T, Kitagawa Y, Hirukawa H, Takesue Y, Saito K, Sato H, Tada T, Choua O, Fu XJ, Yao QY, Yang S, Wang MG, Zhu YL, Cao JX, Shen YM, Togbe JO, Gbessi DG, Dossou FM, Iawani I, Cijan V, Gencic M, Scepanovic M, Bojovic P, Brankovic M, Agresta F, Verza LA, Prando D, Roveran MA, Azabdaftari A, Rubinato L, Vacca U, Lubrano T, Vidotto C, Falcone A, Grasso L, Ghiglione F, Morino M, Nácul M, Cavazzola L, Loureiro M, Bonin E, Ferreira P, Misra MC, Bansal VK, Subodh K, Krisha A, Bansal D, Ray S, Rajeshwari S, Wang P, Jia Z, Zhang FJ, Yan JJ, Zhu YH, Jiang K, Altinli E, Eroglu E, Sertel HI, Hizli F, Jacob B, Bresnaham E, Reiner M, Bates A.
PMID: 26518862
Hernia. 2015 Apr;19:S57-62. doi: 10.1007/BF03355327.

No abstract available.

Cite
Vassiliadis A, Zanoni A, Di Leo A, et al. Inguinal Hernia: Lap vs Open. Hernia. 2015;19:S57-62doi: 10.1007/BF03355327.
Vassiliadis, A., Zanoni, A., Di Leo, A., Zanella, S., Lauro, E., Moscatelli, P., Ricci, F., Huang, H., Wada, N., Furukawa, T., Kitagawa, Y., Hirukawa, H., Takesue, Y., Saito, K., Sato, H., Tada, T., Choua, O., Fu, X. J., Yao, Q. Y., Yang, S., Wang, M. G., Zhu, Y. L., Cao, J. X., Shen, Y. M., Togbe, J. O., Gbessi, D. G., Dossou, F. M., Iawani, I., Cijan, V., Gencic, M., Scepanovic, M., Bojovic, P., Brankovic, M., Agresta, F., Verza, L. A., Prando, D., Roveran, M. A., Azabdaftari, A., Rubinato, L., Vacca, U., Lubrano, T., Vidotto, C., Falcone, A., Grasso, L., Ghiglione, F., Morino, M., Nácul, M., Cavazzola, L., Loureiro, M., Bonin, E., Ferreira, P., Misra, M. C., Bansal, V. K., Subodh, K., Krisha, A., Bansal, D., Ray, S., Rajeshwari, S., Wang, P., Jia, Z., Zhang, F. J., Yan, J. J., Zhu, Y. H., Jiang, K., Altinli, E., Eroglu, E., Sertel, H. I., Hizli, F., Jacob, B., Bresnaham, E., Reiner, M., & Bates, A. (2015). Inguinal Hernia: Lap vs Open. Hernia : the journal of hernias and abdominal wall surgery, 19S57-62. https://doi.org/10.1007/BF03355327
Vassiliadis, A, et al. "Inguinal Hernia: Lap vs Open." Hernia : the journal of hernias and abdominal wall surgery vol. 19 (2015): S57-62. doi: https://doi.org/10.1007/BF03355327
Vassiliadis A, Zanoni A, Di Leo A, Zanella S, Lauro E, Moscatelli P, Ricci F, Huang H, Wada N, Furukawa T, Kitagawa Y, Hirukawa H, Takesue Y, Saito K, Sato H, Tada T, Choua O, Fu XJ, Yao QY, Yang S, Wang MG, Zhu YL, Cao JX, Shen YM, Togbe JO, Gbessi DG, Dossou FM, Iawani I, Cijan V, Gencic M, Scepanovic M, Bojovic P, Brankovic M, Agresta F, Verza LA, Prando D, Roveran MA, Azabdaftari A, Rubinato L, Vacca U, Lubrano T, Vidotto C, Falcone A, Grasso L, Ghiglione F, Morino M, Nácul M, Cavazzola L, Loureiro M, Bonin E, Ferreira P, Misra MC, Bansal VK, Subodh K, Krisha A, Bansal D, Ray S, Rajeshwari S, Wang P, Jia Z, Zhang FJ, Yan JJ, Zhu YH, Jiang K, Altinli E, Eroglu E, Sertel HI, Hizli F, Jacob B, Bresnaham E, Reiner M, Bates A. Inguinal Hernia: Lap vs Open. Hernia. 2015 Apr;19:S57-62. doi: 10.1007/BF03355327. PMID: 26518862.
Copy Download .nbib Format: NLM
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?.

Annals of gastroenterology

Ierardi E, Losurdo G, Iannone A, Piscitelli D, Amoruso A, Barone M, Principi M, Pisani A, Di Leo A.
PMID: 28655974
Ann Gastroenterol. 2017;30(4):380-392. doi: 10.20524/aog.2017.0165. Epub 2017 May 31.

Microscopic enteritis (ME) is characterized by abnormal infiltration of intraepithelial lymphocytes in intestinal mucosa. It was described as duodenal lymphocytosis or lymphocytic duodenitis until the dedicated Consensus Conference of 2015. ME represents a common feature of several gluten-mediated and...

Cite
Ierardi E, Losurdo G, Iannone A, et al. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?. Ann Gastroenterol. 2017;30(4):380-392doi: 10.20524/aog.2017.0165.
Ierardi, E., Losurdo, G., Iannone, A., Piscitelli, D., Amoruso, A., Barone, M., Principi, M., Pisani, A., & Di Leo, A. (2017). Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?. Annals of gastroenterology, 30(4), 380-392. https://doi.org/10.20524/aog.2017.0165
Ierardi, Enzo, et al. "Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?." Annals of gastroenterology vol. 30,4 (2017): 380-392. doi: https://doi.org/10.20524/aog.2017.0165
Ierardi E, Losurdo G, Iannone A, Piscitelli D, Amoruso A, Barone M, Principi M, Pisani A, Di Leo A. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?. Ann Gastroenterol. 2017;30(4):380-392. doi: 10.20524/aog.2017.0165. Epub 2017 May 31. PMID: 28655974; PMCID: PMC5479990.
Copy Download .nbib Format: NLM
The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance.

Obstetrics and gynecology international

Sacchinelli A, Venturella R, Lico D, Di Cello A, Lucia A, Rania E, Cirillo R, Zullo F.
PMID: 24876842
Obstet Gynecol Int. 2014;2014:141020. doi: 10.1155/2014/141020. Epub 2014 Apr 30.

Objective. Substances such as inositol and N-acetylcysteine (NAC) have been recently shown to be effective in treatment of PCOS patients. The aim of this prospective trial is to evaluate the efficacy of NAC + Inositol + folic acid on...

Cite
Sacchinelli A, Venturella R, Lico D, et al. The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. Obstet Gynecol Int. 2014;2014:141020doi: 10.1155/2014/141020.
Sacchinelli, A., Venturella, R., Lico, D., Di Cello, A., Lucia, A., Rania, E., Cirillo, R., & Zullo, F. (2014). The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. Obstetrics and gynecology international, 2014141020. https://doi.org/10.1155/2014/141020
Sacchinelli, Angela, et al. "The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance." Obstetrics and gynecology international vol. 2014 (2014): 141020. doi: https://doi.org/10.1155/2014/141020
Sacchinelli A, Venturella R, Lico D, Di Cello A, Lucia A, Rania E, Cirillo R, Zullo F. The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. Obstet Gynecol Int. 2014;2014:141020. doi: 10.1155/2014/141020. Epub 2014 Apr 30. PMID: 24876842; PMCID: PMC4021745.
Copy Download .nbib Format: NLM
Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation.

Hepatology research : the official journal of the Japan Society of Hepatology

Facciorusso A, Del Prete V, Antonino M, Neve V, Amoruso A, Crucinio N, Di Leo A, Barone M.
PMID: 25472869
Hepatol Res. 2015 Oct;45(10):E62-72. doi: 10.1111/hepr.12458. Epub 2015 Jan 08.

AIM: Survival estimates are commonly reported as survival from the first observation, but future survival probability changes based on the survival time already accumulated after therapy, otherwise known as conditional survival (CS). The aim of the study was to...

Cite
Facciorusso A, Del Prete V, Antonino M, et al. Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatol Res. 2015;45(10):E62-72doi: 10.1111/hepr.12458.
Facciorusso, A., Del Prete, V., Antonino, M., Neve, V., Amoruso, A., Crucinio, N., Di Leo, A., & Barone, M. (2015). Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatology research : the official journal of the Japan Society of Hepatology, 45(10), E62-72. https://doi.org/10.1111/hepr.12458
Facciorusso, Antonio, et al. "Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,10 (2015): E62-72. doi: https://doi.org/10.1111/hepr.12458
Facciorusso A, Del Prete V, Antonino M, Neve V, Amoruso A, Crucinio N, Di Leo A, Barone M. Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatol Res. 2015 Oct;45(10):E62-72. doi: 10.1111/hepr.12458. Epub 2015 Jan 08. PMID: 25472869.
Copy Download .nbib Format: NLM
Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topic.

World journal of hepatology

Licinio R, Principi M, Ierardi E, Di Leo A.
PMID: 25276285
World J Hepatol. 2014 Sep 27;6(9):685-7. doi: 10.4254/wjh.v6.i9.685.

The relationship between primary intestinal lymphangiectasia (PIL) and liver fibrosis is an emerging topic with many obscure aspects due to the rarity of the disorder. A recent paper reported that a six-month low-fat diet improved liver fibrosis. We report...

Cite
Licinio R, Principi M, Ierardi E, et al. Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topic. World J Hepatol. 2014;6(9):685-7doi: 10.4254/wjh.v6.i9.685.
Licinio, R., Principi, M., Ierardi, E., & Di Leo, A. (2014). Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topic. World journal of hepatology, 6(9), 685-7. https://doi.org/10.4254/wjh.v6.i9.685
Licinio, Raffaele, et al. "Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topic." World journal of hepatology vol. 6,9 (2014): 685-7. doi: https://doi.org/10.4254/wjh.v6.i9.685
Licinio R, Principi M, Ierardi E, Di Leo A. Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topic. World J Hepatol. 2014 Sep 27;6(9):685-7. doi: 10.4254/wjh.v6.i9.685. PMID: 25276285; PMCID: PMC4179148.
Copy Download .nbib Format: NLM
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?.

Cancers

Turner N, Pestrin M, Galardi F, De Luca F, Malorni L, Di Leo A.
PMID: 24670368
Cancers (Basel). 2014 Mar 25;6(2):684-707. doi: 10.3390/cancers6020684.

Circulating tumor cell (CTC) count has prognostic significance in metastatic breast cancer, but the predictive utility of CTCs is uncertain. Molecular studies on CTCs have often been limited by a low number of CTCs isolated from a high background...

Cite
Turner N, Pestrin M, Galardi F, et al. Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?. Cancers (Basel). 2014;6(2):684-707doi: 10.3390/cancers6020684.
Turner, N., Pestrin, M., Galardi, F., De Luca, F., Malorni, L., & Di Leo, A. (2014). Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?. Cancers, 6(2), 684-707. https://doi.org/10.3390/cancers6020684
Turner, Natalie, et al. "Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?." Cancers vol. 6,2 (2014): 684-707. doi: https://doi.org/10.3390/cancers6020684
Turner N, Pestrin M, Galardi F, De Luca F, Malorni L, Di Leo A. Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?. Cancers (Basel). 2014 Mar 25;6(2):684-707. doi: 10.3390/cancers6020684. PMID: 24670368; PMCID: PMC4074798.
Copy Download .nbib Format: NLM
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy.

Oncotarget

Bonechi M, Galardi F, Biagioni C, De Luca F, Bergqvist M, Neumüller M, Guarducci C, Boccalini G, Gabellini S, Migliaccio I, Di Leo A, Pestrin M, Malorni L.
PMID: 29662653
Oncotarget. 2018 Mar 27;9(23):16389-16399. doi: 10.18632/oncotarget.24700. eCollection 2018 Mar 27.

The aim of this study was to investigate if thymidine kinase-1 (TK1), a well-known proliferation marker, could represent a valid circulating biomarker to identify hormone receptor positive (HR+)/HER2 negative (HER2neg) metastatic breast cancer (MBC) patients most likely to benefit...

Cite
Bonechi M, Galardi F, Biagioni C, et al. Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy. Oncotarget. 2018;9(23):16389-16399doi: 10.18632/oncotarget.24700.
Bonechi, M., Galardi, F., Biagioni, C., De Luca, F., Bergqvist, M., Neumüller, M., Guarducci, C., Boccalini, G., Gabellini, S., Migliaccio, I., Di Leo, A., Pestrin, M., & Malorni, L. (2018). Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy. Oncotarget, 9(23), 16389-16399. https://doi.org/10.18632/oncotarget.24700
Bonechi, Martina, et al. "Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy." Oncotarget vol. 9,23 (2018): 16389-16399. doi: https://doi.org/10.18632/oncotarget.24700
Bonechi M, Galardi F, Biagioni C, De Luca F, Bergqvist M, Neumüller M, Guarducci C, Boccalini G, Gabellini S, Migliaccio I, Di Leo A, Pestrin M, Malorni L. Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy. Oncotarget. 2018 Mar 27;9(23):16389-16399. doi: 10.18632/oncotarget.24700. eCollection 2018 Mar 27. PMID: 29662653; PMCID: PMC5893248.
Copy Download .nbib Format: NLM
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery.

Hematology reports

Sottilotta G, Luise F, Oriana V, Piromalli A, Santacroce R, Di Lelio A.
PMID: 30915205
Hematol Rep. 2019 Feb 19;11(1):7912. doi: 10.4081/hr.2019.7912. eCollection 2019 Feb 19.

Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right...

Cite
Sottilotta G, Luise F, Oriana V, et al. Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery. Hematol Rep. 2019;11(1):7912doi: 10.4081/hr.2019.7912.
Sottilotta, G., Luise, F., Oriana, V., Piromalli, A., Santacroce, R., & Di Lelio, A. (2019). Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery. Hematology reports, 11(1), 7912. https://doi.org/10.4081/hr.2019.7912
Sottilotta, Gianluca, et al. "Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery." Hematology reports vol. 11,1 (2019): 7912. doi: https://doi.org/10.4081/hr.2019.7912
Sottilotta G, Luise F, Oriana V, Piromalli A, Santacroce R, Di Lelio A. Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery. Hematol Rep. 2019 Feb 19;11(1):7912. doi: 10.4081/hr.2019.7912. eCollection 2019 Feb 19. PMID: 30915205; PMCID: PMC6397991.
Copy Download .nbib Format: NLM
A multifactorial 'Consensus Signature' by .

NPJ breast cancer

Turner N, Forcato M, Nuzzo S, Malorni L, Bicciato S, Di Leo A.
PMID: 28721363
NPJ Breast Cancer. 2015 Jun 02;1:15003. doi: 10.1038/npjbcancer.2015.3. eCollection 2015.

RESULTS: In the training set, 29 of 147 patients had pCR after anthracycline-based chemotherapy. Various combinations of components were evaluated, with the most powerful anthracycline response predictors being CONCLUSIONS: With further validation,

Cite
Turner N, Forcato M, Nuzzo S, et al. A multifactorial 'Consensus Signature' by . NPJ Breast Cancer. 2015;1:15003doi: 10.1038/npjbcancer.2015.3.
Turner, N., Forcato, M., Nuzzo, S., Malorni, L., Bicciato, S., & Di Leo, A. (2015). A multifactorial 'Consensus Signature' by . NPJ breast cancer, 115003. https://doi.org/10.1038/npjbcancer.2015.3
Turner, Natalie, et al. "A multifactorial 'Consensus Signature' by ." NPJ breast cancer vol. 1 (2015): 15003. doi: https://doi.org/10.1038/npjbcancer.2015.3
Turner N, Forcato M, Nuzzo S, Malorni L, Bicciato S, Di Leo A. A multifactorial 'Consensus Signature' by . NPJ Breast Cancer. 2015 Jun 02;1:15003. doi: 10.1038/npjbcancer.2015.3. eCollection 2015. PMID: 28721363; PMCID: PMC5515202.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 162 entries